Abstract

Background: Although the combination of high blood pressure (HBP) and type 2 diabetes (T2DM) increases the risk of left ventricular (LV) dysfunction, the impact of T2DM on LV geometry and subclinical dysfunction in hypertensive patients and normal ejection fraction (EF) has been infrequently evaluated. Methods: Hypertensive patients with or without T2DM underwent cardiac echocardiography coupled with LV global longitudinal strain (GLS) assessment. Results: Among 200 patients with HBP (mean age 61.7 ± 9.7 years) and EF > 55%, 93 had associated T2DM. Patients with T2DM had a higher body mass index (29.9 ± 5.1 kg/m2 vs. 29.3 ± 4.7 kg/m2, p = 0.025), higher BP levels (158 ± 23/95 ± 13 vs. 142 ± 33/87 ± 12 mmHg, p = 0.003), a higher LV mass index (115.8 ± 32.4 vs. 112.0 ± 24.7 g/m2, p = 0.004), and higher relative wall thickness (0.51 ± 0.16 vs. 0.46 ± 0.12, p = 0.0001). They had more frequently concentric remodeling (20.4% vs. 16.8%, p < 0.001), concentric hypertrophy (53.7% vs. 48.6%, p < 0.001), elevated filling pressures (25.8 vs. 12.1%, p = 0.0001), indexed left atrial volumes greater than 28 mL/m2 (17.2 vs. 11.2%, p = 0.001), and a reduced GLS less than −18% (74.2 vs. 47.7%, p < 0.0001). After adjustment for BP and BMI, T2DM remains an independent determinant factor for GLS decline (OR = 2.26, 95% CI 1.11–4.61, p = 0.023). Conclusions: Left ventricular geometry and subclinical LV function as assessed with GLS are more impaired in hypertensive patients with than without T2DM. Preventive approaches to control BMI and risk of T2DM in hypertensive patients should be emphasized.

Highlights

  • The colluding effects of the two most common noncommunicable diseases, hypertension and type 2 diabetes mellitus (T2DM), result in a severalfold elevation in risk for cardiovascular morbidity and mortality [1]

  • This study investigates the impact on subclinical cardiac function of concomitant diabetes in a cohort of patients with high blood pressure (HBP)

  • Early impairment of global longitudinal strain (GLS) is observed in patients with T2DM [5,17], which is worsened by coexistent hypertension [18,19,20]

Read more

Summary

Introduction

The colluding effects of the two most common noncommunicable diseases, hypertension and type 2 diabetes mellitus (T2DM), result in a severalfold elevation in risk for cardiovascular morbidity and mortality [1]. The combination of high blood pressure (HBP) and type 2 diabetes (T2DM) increases the risk of left ventricular (LV) dysfunction, the impact of T2DM on LV geometry and subclinical dysfunction in hypertensive patients and normal ejection fraction (EF) has been infrequently evaluated. Patients with T2DM had a higher body mass index (29.9 ± 5.1 kg/m2 vs 29.3 ± 4.7 kg/m2 , p = 0.025), higher BP levels (158 ± 23/95 ± 13 vs 142 ± 33/87 ± 12 mmHg, p = 0.003), a higher LV mass index (115.8 ± 32.4 vs 112.0 ± 24.7 g/m2 , p = 0.004), and higher relative wall thickness (0.51 ± 0.16 vs 0.46 ± 0.12, p = 0.0001) They had more frequently concentric remodeling (20.4% vs 16.8%, p < 0.001), concentric hypertrophy (53.7% vs 48.6%, p < 0.001), elevated filling pressures

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call